How to Tell the Difference Between IBS and Pancreatitis

Irritable bowel syndrome and pancreatitis can produce strikingly similar symptoms, particularly abdominal pain and diarrhea, but they are fundamentally different conditions with different causes, different risks, and different treatments. IBS is a disorder of gut-brain interaction with no structural damage to the digestive organs, while pancreatitis involves actual inflammation and potential destruction of the pancreas. Telling them apart matters because one condition is managed mainly with dietary changes and symptom control, while the other can become a medical emergency or, in its chronic form, permanently impair digestion and blood sugar regulation.

Where the Symptoms Look Alike

The core reason people confuse IBS and pancreatitis is that both can cause recurring abdominal pain, bloating, and changes in bowel habits. Someone with diarrhea-predominant IBS deals with loose stools and cramping that can flare for weeks at a time, and someone with chronic pancreatitis can experience nearly identical complaints. A narrative review examining the differential diagnosis of chronic diarrhea highlighted that the considerable overlap of symptoms between IBS with diarrhea and exocrine pancreatic insufficiency makes accurate diagnosis “problematic” and can lead to delays or outright misdiagnosis.¹ The confusion is especially tricky with chronic pancreatitis, whose episodes of abdominal pain can be clinically and biochemically indistinguishable from an acute flare.²

Both conditions also tend to worsen after eating. IBS pain is often triggered by certain foods, stress, or hormonal changes, and it frequently improves after a bowel movement. Pancreatitis pain, by contrast, classically radiates to the back and often intensifies after meals, particularly fatty ones, without much relief from passing stool. But in real life, these textbook distinctions are blurry. Not everyone with pancreatitis has back-radiating pain, and not everyone with IBS feels better after going to the bathroom.

Red Flags That Point Away From IBS

IBS is what doctors call a diagnosis of exclusion, but that does not mean the process has to be exhausting. Under current guidelines, IBS can be diagnosed positively by confirming the characteristic symptom pattern and checking for “red flag” features that would suggest something else is going on. Those red flags include unintentional weight loss, blood in the stool, anemia, fever, and a family history of conditions like inflammatory bowel disease or colorectal cancer.³ If none of those are present and the symptom pattern fits, guidelines in both the United States and the United Kingdom advise against ordering routine imaging, because the diagnosis is likely IBS.⁴

Pancreatitis, on the other hand, almost always comes with at least one red flag. Acute pancreatitis typically announces itself with severe upper abdominal pain, nausea, vomiting, and often a fever. Chronic pancreatitis tends to cause progressive weight loss because the pancreas gradually loses its ability to produce the enzymes needed to digest food, especially fat. When fat goes undigested, stools become pale, greasy, foul-smelling, and difficult to flush. That kind of stool is not something you see with IBS. If you are losing weight without trying, if your stools float and look oily, or if pain is getting steadily worse over months rather than waxing and waning in a familiar pattern, those signs warrant a workup that goes beyond an IBS diagnosis.

What Blood Tests Reveal

Blood work is one of the clearest ways to separate the two. IBS does not produce abnormal blood markers. You can run a complete blood count, a metabolic panel, and inflammatory markers on someone with IBS and everything will come back normal. That normalcy is actually part of how doctors confirm the diagnosis.

Acute pancreatitis is a different story. Serum lipase is the most reliable blood test for it. In one study of patients with acute pancreatitis, lipase was elevated in every single case, and pancreatic isoamylase was elevated in almost all of them.⁵ Amylase, the older and more commonly ordered test, was elevated in about 88% of those cases, making it slightly less sensitive. Among patients with abdominal pain from non-pancreatic causes, false elevations were rare for lipase (around 6%) but somewhat more common for other enzymes. So if your doctor orders a lipase level and it comes back elevated, that is strong evidence of pancreatic inflammation rather than IBS.

Inflammatory markers also help gauge severity once pancreatitis is suspected. C-reactive protein (CRP) levels above 100 mg/L and white blood cell counts above 12,000 were significantly more common in patients with severe acute pancreatitis than in mild cases, and CRP emerged as the strongest independent predictor of complications and prolonged hospitalization.⁶ None of these inflammatory shifts happen with IBS.

The Stool Test That Catches What Blood Work Misses

Blood tests are excellent at catching acute pancreatitis, but chronic pancreatitis is sneakier. By the time it has been smoldering for years, the pancreas may no longer be inflamed enough to push blood enzymes upward. Instead, the problem becomes exocrine pancreatic insufficiency (EPI), meaning the pancreas is not producing enough digestive enzymes. This is where a stool test called fecal elastase-1 becomes useful.

Fecal elastase-1 measures the amount of a specific pancreatic enzyme in your stool. A low result, particularly below 100 micrograms per gram of stool, strongly suggests the pancreas is underperforming. In a study of patients with diarrhea-predominant IBS, about 6% had fecal elastase levels that low, suggesting that some people carrying an IBS diagnosis actually had undiagnosed pancreatic insufficiency.⁷ A more recent study using stricter diagnostic criteria (Rome IV) found EPI in about 5% of diarrhea-predominant IBS patients, with pancreatic steatosis visible on endoscopic ultrasound in most of those cases.⁸

Five or six percent may not sound like a lot, but diarrhea-predominant IBS is common, so the absolute number of misdiagnosed people adds up. If you have been told you have IBS-D and standard treatments like dietary modification or antispasmodics have not worked, asking for a fecal elastase test is a reasonable next step. The test is noninvasive, inexpensive, and widely available.

When Imaging Becomes Necessary

For a typical IBS presentation without red flags, imaging adds nothing and is not recommended. But when symptoms suggest something structural, scans help clarify what is happening to the pancreas itself. CT scans can reveal pancreatic calcifications, duct dilation, and atrophy, all hallmarks of chronic pancreatitis. MRI with a special protocol called MRCP can provide detailed images of the pancreatic duct without radiation.

For earlier or subtler changes, endoscopic ultrasound (EUS) has become one of the go-to tools. EUS can detect both severe and subtle abnormalities in the pancreatic tissue and duct that other imaging methods miss, and it carries less risk than older techniques like ERCP, which require threading instruments into the duct itself.⁹ The choice of imaging should be guided by the clinical picture. If a doctor suspects early chronic pancreatitis, EUS is often the first advanced test ordered. If the concern is a mass or complications like a pseudocyst, CT or MRI typically leads.

Crucially, imaging is also what distinguishes chronic pancreatitis from IBS in those gray-zone patients who have ongoing pain and diarrhea but unremarkable blood work. The pancreas can be structurally damaged long before blood tests turn abnormal, and imaging can reveal that damage directly.

Why the Diagnostic Path Is Not Always Straightforward

There is no single algorithm that doctors follow when a patient shows up with persistent abdominal pain and diarrhea. A review of persistent abdominal pain beyond IBS concluded that specific diagnostic protocols for this situation simply do not exist and that investigations should be tailored case by case based on history and physical findings.¹⁰ This can be frustrating if you are the patient, because it means the speed and thoroughness of your workup depends heavily on what your particular doctor thinks to look for.

The practical takeaway is that you need to be a good historian of your own symptoms. Pain location, timing relative to meals, what makes it better or worse, the appearance of your stool, any unintended weight changes, your alcohol and smoking history, and how your symptoms have changed over time are all critical details. A doctor who hears “belly pain and diarrhea” may reasonably think IBS first. A doctor who hears “belly pain that radiates to my back after eating fatty meals, loose greasy stools, and I’ve lost ten pounds in six months” is going to think pancreas. The facts are the same, but the framing changes the diagnostic direction.

Alcohol, Smoking, and Pancreatic Risk

Risk factor history is one of the most underappreciated tools for sorting IBS from pancreatitis. IBS has no strong association with alcohol or tobacco use. Pancreatitis does. In a multivariate analysis, independent risk factors for chronic pancreatitis included male sex, smoking more than about five to six cigarettes a day, and drinking more than roughly one and a half standard drinks per day.¹¹ The risk from even moderate daily drinking was substantial, with odds roughly six times higher than in non-drinkers.

This does not mean only heavy drinkers get pancreatitis. Idiopathic chronic pancreatitis, meaning cases with no identifiable cause, accounts for a significant chunk of diagnoses. But if you are someone with IBS-like symptoms who also drinks regularly and smokes, the probability that the pancreas is involved goes up meaningfully, and it is worth making sure your doctor knows those details.

When IBS Treatment Fails, Reconsider the Diagnosis

One of the most practical signals that something beyond IBS may be going on is treatment response. If you have faithfully tried dietary changes, fiber supplements, antispasmodics, and perhaps low-FODMAP eating for months without meaningful improvement, that resistance to typical IBS therapies should prompt a second look. In the study that found hidden pancreatic insufficiency among IBS-D patients, those who were given pancreatic enzyme supplements showed a striking improvement: about 58% reported reduced abdominal pain after treatment, compared with roughly 7% of the group that did not receive enzymes.⁷

This underscores that IBS and pancreatic insufficiency are not just diagnostically different but therapeutically different. The enzymes that help EPI do nothing for IBS, and the gut-brain therapies that help IBS do nothing for a failing pancreas. Getting the diagnosis right determines whether treatment works.

Chronic Pancreatitis and the Progression Problem

An important distinction between IBS and chronic pancreatitis is trajectory. IBS symptoms can fluctuate for years or even decades, but the condition does not cause progressive organ damage. Chronic pancreatitis, by contrast, involves irreversible structural changes to the pancreas. Over time, both the exocrine function (enzyme production for digestion) and endocrine function (insulin production for blood sugar control) deteriorate permanently.² That means chronic pancreatitis can eventually cause diabetes in addition to malabsorption, a complication that does not arise from IBS.

This progressive nature also means that catching chronic pancreatitis early, rather than dismissing symptoms as “just IBS,” genuinely changes outcomes. Identifying pancreatic insufficiency early allows enzyme replacement therapy to improve nutrition before deficiencies become severe. Recognizing the early stages of chronic pancreatitis lets doctors address modifiable risk factors like alcohol and tobacco use before the damage compounds.

Small Intestinal Bacterial Overgrowth as a Complicating Factor

One reason chronic pancreatitis symptoms can be especially confusing is that the condition frequently brings along a secondary problem: small intestinal bacterial overgrowth, or SIBO. When undigested food sits in the gut because pancreatic enzymes are insufficient, bacteria proliferate in the small intestine where they normally should not be abundant. SIBO causes bloating, gas, diarrhea, and abdominal discomfort, which are all symptoms that look like IBS on the surface.

Studies consistently find SIBO at significantly higher rates in chronic pancreatitis patients than in healthy people. One study found positive breath tests in about 41% of chronic pancreatitis patients, far above the roughly 16% rate seen in age-matched healthy controls.¹² Another found SIBO in about 15% of chronic pancreatitis patients versus none in healthy controls, with higher rates in those who also had diabetes, used proton pump inhibitors, or had alcohol-related disease.¹³ SIBO was equally common whether the pancreatitis was caused by alcohol or had no identifiable cause.¹⁴

The practical implication is that if you have chronic pancreatitis and enzyme replacement therapy has improved your digestion but you still have significant bloating and gas, SIBO may be layered on top. Treating it typically involves a course of antibiotics. What you do not want is to be told you have IBS and given lifestyle advice when the real issue is a treatable bacterial overgrowth driven by an underlying pancreatic problem.

A Side-by-Side Symptom Comparison

Because the overlap can be genuinely confusing, here is a practical checklist of features that tend to differ between IBS and pancreatitis, keeping in mind that no single item is diagnostic on its own:

• Pain pattern: IBS pain is often diffuse, crampy, and relieved by bowel movements. Pancreatitis pain is typically in the upper abdomen, may bore through to the back, and worsens after eating fatty foods.
• Stool quality: IBS diarrhea is usually watery or loose but not oily. Pancreatitis-related diarrhea often produces pale, greasy, floating stools with a particularly strong odor.
• Weight change: IBS rarely causes significant weight loss. Chronic pancreatitis commonly does, because nutrients are not being absorbed properly.
• Blood markers: Normal in IBS. Lipase and amylase rise in acute pancreatitis; CRP and white blood cells may be elevated in severe cases.
• Stool elastase: Normal in IBS. Low in pancreatic insufficiency.
• Risk factors: IBS is linked to stress, visceral hypersensitivity, and sometimes food triggers. Pancreatitis is linked to alcohol use, smoking, gallstones, and certain genetic conditions.
• Disease course: IBS waxes and wanes without structural damage. Chronic pancreatitis progresses, causing irreversible changes to the organ and potentially leading to diabetes.

When Both Diagnoses Might Coexist

It is worth noting that having pancreatitis does not make you immune to IBS, and having IBS does not protect you from developing pancreatic disease. Some patients genuinely have both. The gut-brain signaling disruptions that drive IBS can exist alongside structural pancreatic damage, particularly in someone who developed chronic pancreatitis first and then found that the resulting changes to digestion and gut bacteria triggered IBS-type symptoms on top. Distinguishing which symptoms come from which condition in a patient who has both requires careful, sequential testing: treating the pancreatic insufficiency with enzyme replacement first, assessing what symptoms resolve, and then addressing whatever remains as a possible gut-brain interaction problem.

The bigger danger, frankly, runs in the other direction: having pancreatitis misdiagnosed as IBS. Pancreatic disease can be elusive in its early stages, and its symptoms overlap enough with IBS that it is easier than it should be to miss.¹⁵ If you have been diagnosed with IBS but your symptoms include oily stools, progressive weight loss, worsening pain after meals, or a history of significant alcohol use, a fecal elastase test and possibly imaging are warranted to make sure the pancreas is not the real problem.